Janssen seeks expansion into psoriatic arthritis with latest Tremfya FDA filing
Tremfya is already approved across seven major markets for psoriasis and was approved for psoriatic arthritis in Japan in April...
Trending menu:
-
![Akari enrols seven out of nine patients in bullous pemphigoid trial]()
Akari enrols seven out of nine patients in bullous pemphigoid trial
-
![Cassiopea’s Winlevi uptake in acne driven by new mechanism though interest to wane]()
Cassiopea’s Winlevi uptake in acne driven by new mechanism though interest to wane
-
![AstraZeneca’s Imfinzi falls at another hurdle in non-small cell lung cancer trial]()
AstraZeneca’s Imfinzi falls at another hurdle in non-small cell lung cancer trial
-
![The most researched drugs in cystic fibrosis trials]()
The most researched drugs in cystic fibrosis trials
-
![Improved clinical efficacy found wanting in Phase III IMPALA trial]()
Improved clinical efficacy found wanting in Phase III IMPALA trial
-
![New, efficacious options offer hope for Ebola treatment and containment]()
New, efficacious options offer hope for Ebola treatment and containment
Expert commentary & analysis from GlobalData
Karuna’s Phase II schizophrenia trial prompts expert caution
Theravance to recruit 120 trial sites for Phase III trial in neurogenic orthostatic hypotension
KalVista’s hereditary angioedema treatment draws uncertainty
Taltz knocks down Tremfya in head-to-head trial in psoriasis patients
Most Read
Company releases
3DforScience to Exhibit at the Partnering Convention, 11-13 November
BIO Europe Partnering is a premier bioscience conference, which brings nearly 5,000 delegates from a broad range of companies in...
ASTM International to Hold Board Meeting and Events in Boston on 13-16 October
Two Powerful New Stirrers by IKA
A fresh generation of hi-tech stirrers is awaiting users in the laboratory, including the RCT 5 digital, one of the...
Visuals for Bio&Health
Industry Leaders Come on Board as NMiTE Adds Engineering Expertise
The New Model in Technology and Engineering (NMiTE) has announced three appointments to its Board...
Company whitepapers
IKA Laboratory Equipment Brochure
Ika-WerkePrimary Cells Isolated from Healthy Human and Animal Tissues
Caltag MedsystemsImprove Endpoint Adjudication Efficiency with Ethical™ Adjudication®
EthicalIKA Case Study: Sustainable Processes for Textile Surfaces
Ika-WerkeSTZ-Induced Rat Model of Diabetes
Noble Life SciencesVisuals for Bio&Health
3DforScienceStudy: Comparing Efficacy and Tolerability of New Daily Oral Vitamin B12 and Intermittent Intramuscular Vitamin B12
Emisphere TechnologiesCompany A-Z
Clinical Trials
OPKO Health and Pfizer report positive Phase III data for somatrogon
OPKO Health and Pfizer have reported positive results from the Phase III clinical trial of somatrogon compared to Genotropin (somatropin) in children suffering from growth...
Tecentriq and Avastin improves survival in Phase III cancer trial
Janssen reports two-year UNIFI data for Stelara in ulcerative colitis
Imugene to study oncolytic virus products in Phase I trials
Bavarian Nordic reports Phase II bladder cancer trial data
Drug Development
Tecentriq and Avastin improves survival in Phase III cancer trial
Roche has reported that the Phase III IMbrave150 clinical trial of Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) met the co-primary endpoints in hepatocellular carcinoma...
FDA accepts BLA from AstraZeneca and Daiichi for targeted chemotherapy
Lilly’s pegilodecakin fails in Phase III pancreatic cancer trial
Novartis-Incyte’s Jakavi yields positive data in GvHD trial
Pfizer’s abrocitinib meets all endpoints in JADE MONO-1 study
Go Top